In 2018, 21.5 lakh tuberculosis (TB) cases were reported to the government, as compared to 18 lakh in 2017, an increase of 17 per cent in one year. A new drug known as delamanid would be ...

side effects, and administration guidelines for each medication. A dedicated FAQ section is available for common drugs to address questions and provide a deeper understanding of Tuberculosis ...

This page compiles essential information on generic and brand-name drugs specifically used for Stomach Tuberculosis treatment.Here, you can explore dosages, prices, side effects, and ...

Multidrug resistant tuberculosis (MDR-TB) is a serious, life-threatening illness with evolving treatment regimens for better ...

Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...

A new study indicates resistance to shorter and less toxic drug regimens for multidrug-resistant tuberculosis (MDR-TB) is emerging and spreading between patients.

They identified a total of 514 strains that were resistant to TB drugs, including both the old and the new treatment regimens. These highly drug-resistant strains were found in 27 countries across ...

TB is among Kenya's top three killer diseases, alongside malaria and HIV/AIDS. [iStockphoto] Kenya is likely to lose gains made in the fight against Tuberculosis (TB), a leading infectious disease ...

The Health Ministry has dismissed media reports claiming a shortage of anti-tuberculosis (TB) drugs in India, labelling them as "incorrect and misleading". In a statement, the Ministry emphasised ...